[在老年AML患者中对HLA不匹配的异构造血细胞干细胞微移植后细胞免疫功能恢复的分析]

Shan Jiang1, Ru-Yu Liu2, Tie-Qiang Liu2

  • 1The PLA 307 Clinical College of Anhui Medical University, The Fifth Clinical Medical College of Anhui Medical University, Hefei 230032, Anhui Province, China.

概括

微移植 (MST) 增强老年急性髓性白血病 (AML) 患者的细胞免疫力,增强T细胞. 在低风险患者中,免疫恢复更好,但B和NK细胞在治疗后仍然很低.